| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 02/07/2001 | EP1073448A1 Fertility improving composition and application thereof |
| 02/07/2001 | EP0904084A4 Emergency contraceptive kit |
| 02/07/2001 | CN1283200A Androfenic Steroid compounds and method of making and using the same |
| 02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 02/07/2001 | CN1282743A New beta-carbiline compounds, their preparation method and medicine composition conterning same |
| 02/07/2001 | CN1282740A Intermediate compound for preparing xibo ketone |
| 02/07/2001 | CN1282589A Medical capsule for reinforcing vital energy of kidney and making body stronger |
| 02/07/2001 | CN1282584A Application of icariin in preventing and treating sexual disfunction and improving diseases associated with vasoconstriction |
| 02/07/2001 | CN1061658C Tricyclic benzazepine vasopression antagonists |
| 02/07/2001 | CN1061551C Traditional chinese medicine for curing leukoplakia valvae of gynecopathy |
| 02/07/2001 | CN1061547C Nutritious oral liquid for improving quality and quantity of woman milk and preparation method thereof |
| 02/07/2001 | CN1061544C Compound epimedium ointment |
| 02/07/2001 | CN1061542C Medicine for treating mastadenitis |
| 02/06/2001 | US6184244 C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/06/2001 | US6184231 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 02/06/2001 | US6183991 Nucleotide and amino acid sequence; recombinant production of polypeptide; enhancing viability of cryopreserved sperm, sperm motility, and fertilization in assisted reproduction; contraceptives |
| 02/06/2001 | US6183769 Methods of enhancing reproductive performance of animals |
| 02/06/2001 | CA2155872C Oxytocin antagonist |
| 02/05/2001 | CA2314867A1 2,7-substituted octahydro-1h-pyrido¬1,2-a|pyrazine derivatives as ligands for serotonin receptors |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007483A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 02/01/2001 | WO2001007477A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007462A1 11β-ARYL-17,17-SPIROTHIOLANE-SUBSTITUTED STEROIDS |
| 02/01/2001 | WO2001007441A1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES |
| 02/01/2001 | WO2001007434A2 Indole derivatives and their use as 5ht2a ligands |
| 02/01/2001 | WO2001007424A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 02/01/2001 | WO2001007074A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | WO2001007035A1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 02/01/2001 | WO2001007032A1 Th2 differentiation inhibitors |
| 02/01/2001 | WO2001007021A2 Process for the improvement of spermatozoa fertilization activity |
| 02/01/2001 | WO2000067735A3 USE OF SELECTIVE ANTAGONISTS OF THE α1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION |
| 02/01/2001 | WO2000063248A3 Highly purified gonadotropin compositions and process for preparing them |
| 02/01/2001 | WO2000040226A3 Method of treating sexual disturbances |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | DE19934432A1 Indolderivate Indole derivatives |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380181A1 8-phenyl-6,9-dihydro-¬1,2,4|triazolo¬3,4-i|purin-5-one derivatives |
| 02/01/2001 | CA2380037A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2378845A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | CA2378650A1 Process for the improvement of spermatozoa fertilization activity |
| 02/01/2001 | CA2375982A1 Th2 differentiation inhibitors |
| 01/31/2001 | EP1072597A1 Pyrazoles and their use as endothelin antagonists |
| 01/31/2001 | EP1072592A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1071822A2 Fetal testing for prediction of low birth weight |
| 01/31/2001 | EP1071455A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 01/31/2001 | EP1071446A2 Regulation of ovarian maturation and function using epidermal growth factor |
| 01/31/2001 | EP1071428A2 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 01/31/2001 | EP1071423A1 Antagonists of gonadotropin releasing hormone |
| 01/31/2001 | EP1071421A1 Pharmaceutical imidazole combination for locally treating vulvovaginitis and vaginosis |
| 01/31/2001 | CN1282250A Progestin therapy with controlled bleeding |
| 01/31/2001 | CN1282248A Combination effective for treatment of impotence |
| 01/31/2001 | CN1281698A Medicine composition and its application |
| 01/31/2001 | CN1061235C Pharmaceutical composition for prophlaxis and treatment of premature ejaculation caused by neuroticism |
| 01/30/2001 | US6180665 Crystalline polymorphic form of (S,S,S)-N-(1-[2-carboxy-3 (N2-mesyllyslamino) propyl]-1- cyclopentylcarbonyl) tyrosine |
| 01/30/2001 | US6180664 Pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 01/30/2001 | US6180647 Gastrointestinal disorders; nervous system disorders |
| 01/30/2001 | US6180608 Packaged formulation for treating a subject for a condition treatable with an lhrh analogue, comprising ionic complex of lhrh analogue and carrier macromolecule |
| 01/30/2001 | CA2011171C Biodegradable poly (phosphate esters) |
| 01/29/2001 | CA2314682A1 A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |
| 01/25/2001 | WO2001005947A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | WO2001005833A1 Odorant receptors |
| 01/25/2001 | WO2001005806A1 Orally active androgens |
| 01/25/2001 | WO2001005790A1 New compounds |
| 01/25/2001 | WO2001005776A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 01/25/2001 | WO2001005770A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 01/25/2001 | WO2001005435A2 Antisense therapy for hormone-regulated tumors |
| 01/25/2001 | WO2001005415A2 Composition having steroidal estrogen effect without increasing the risk of breast cancer |
| 01/25/2001 | WO2001005380A1 Sustained release compositions, process for producing the same and use thereof |
| 01/25/2001 | WO2000059946A8 Hydroxymatairesinol in cancer prevention |
| 01/25/2001 | WO2000056296A3 Compositions for improving fertility |
| 01/25/2001 | DE19934585A1 Treatment of dermatological disorders, e.g. pruritus, herpes simplex infection, psoriasis or acne, using tosyl chloramide salt, e.g. in ointment or gel base |
| 01/25/2001 | CA2380000A1 Odorant receptors |
| 01/25/2001 | CA2379554A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 01/25/2001 | CA2379223A1 Orally active androgens |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378917A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | CA2378714A1 Sustained release compositions, methods for producing the same and uses thereof |
| 01/25/2001 | CA2378202A1 New compounds |
| 01/25/2001 | CA2375467A1 Antisense therapy for hormone-regulated tumors |
| 01/24/2001 | EP1070716A1 Beta-carboline derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/24/2001 | EP1070065A1 Azabicyclic 5ht1 receptor ligands |
| 01/24/2001 | EP1070064A1 Antagonists of gonadotropin releasing hormone |
| 01/24/2001 | EP1070059A1 Chromanone and thiochromanone derivatives |
| 01/24/2001 | EP0931080A4 Amorphous paroxetine composition |
| 01/24/2001 | EP0788513B1 Use of binding agents to cd23 in the treatment of autoimmune diseases |
| 01/24/2001 | CN1281455A 8-Azabicyclo [3,2,1] octane-3-methanamine derivatives as ligands of D2 and D3 dopamine and 5HT1A and 5HT2 serotonin receptors |
| 01/24/2001 | CN1281429A Novel aryloxy-alkyl-dialkylamines |
| 01/24/2001 | CN1281367A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 01/24/2001 | CN1281363A Progestogen-antiprogestogen regimens |
| 01/24/2001 | CN1281361A Use of aromatase inhibitor in treatment of uropoiesis disease and method for studying uropoiesis disease |
| 01/24/2001 | CN1280832A Chinese-medicinal capsule for treating impotence |
| 01/24/2001 | CN1061052C 11 Beta-aromatic group-4-estraene and acid additive salt application in medicine |
| 01/24/2001 | CN1061042C Adhesion receptor antagonists |
| 01/23/2001 | US6177556 Nucleotide sequences coding stem cell factor protein; for use in in vitro fertilization therapy |
| 01/23/2001 | US6177550 Process for extraction of a growth factor complex |
| 01/23/2001 | US6177429 Dihydropyrazine derivatives as NPY antagonists |